Kieser Brian Joseph bought NXGL

November 10, 2026 · Form 4 insider transaction

Kieser Brian Joseph bought 133,216 shares of NEXGEL, Inc. at $5.50 per share, a transaction worth $732.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
133,216
Price
$5.50
Total value
$732.7K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 10, 2026
Filing dateNovember 13, 2026
Shares owned after133,216
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects the purchase by Sequence LifeScience, Inc. ("Sequence") on November 10, 2026 of 133,216 units from the Issuer, each unit consisting of one share of Common Stock and a warrant to purchase one share of Common Stock (the "PIPE Warrant"), at $5.50 per unit, in a private placement under a Securities Purchase Agreement. No separate consideration was paid for the PIPE Warrant. The closing occurred on November 10, 2026. The PIPE Warrant has an original issue date of November 10, 2026, is exercisable for cash at $10.00 per share, and expires on the fifth anniversary of its original issue date. The Issuer has waived the beneficial-ownership limitation that would otherwise apply to these securities.; Share and underlying-share amounts reflect the 1-for-20 reverse stock split of the Issuer's common stock effective October 12, 2026.; The securities are held of record by Sequence. The Reporting Person is the indirect sole owner of Sequence and may be deemed to have voting and investment power over the securities held by Sequence. The Reporting Person disclaims beneficial ownership of the securities held by Sequence except to the extent of his pecuniary interest therein.

View the original Form 4 on SEC EDGAR